Clinical trial
Reactogenicity and Immunogenicity of Third Dose Vaccine Booster Following Two Doses of Inactivated Vaccines
NCT05095298 is registered in ClinicalTrials.gov with Huashan Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Reactogenicity and Immunogenicity of Third Dose Vaccine Booster Following Two Doses of Inactivated Vaccines
- Lead sponsor
- Huashan Hospital
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- August 1, 2021
- Completion date
- August 1, 2022
- Enrollment
- 400 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.